For Immediate Release
Chicago, IL – February 7, 2012 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Telus Corporation ( (TU - Free Report) , Allscripts ( (MDRX - Free Report) , Quality Systems ( (QSII - Free Report) , Rogers Communication ( (RCI - Free Report) and BCE Inc. ( (BCE - Free Report) .
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: https://at.zacks.com/?id=5513
Here are highlights from Monday’s Analyst Blog:
Telus Enters Cloud-Based EMR Biz
Telus Health Solutions, a division of Telus Corporation ( (TU - Free Report) has recently announced the acquisition of Wolf Medical Systems, a leading electronic medical records (EMR) company providing cloud-based EMR services across Canada in the health space.
Although the financial details of the deal has not been disclosed, the collaboration is expected to boost EMR services further by combining Wolf's advanced cloud-based EMR technology with Telus' wireless and wireline broadband communications networks.
Given the rapid development of information technology in every industry, the healthcare sector remains no exception. Further, the need for electronic data storage solutions is also growing at a faster space in this arena, replacing paper-based records.
Computerized health information systems have become popular over their two decades of existence, and EMR remains at a core of this technology for providing integrated healthcare solutions. The market has registered a boom in the last couple of years following federal government legislation that requires medical providers to modernize their systems.
The addition of cloud-based technology has further enhanced this service in terms of security and reliability of records, and generating increased market traction. This mode of paperless and easily accessible medical records has aided many healthcare professionals and is expected to dominate a significant market share in future given its growing importance.
According to sources, the electronic health records market is expected to reach approximately $6 billion by 2015 in the U.S. As a result, telecom companies like TELUS are aggressively focusing on this new genre of technological advancement.
Although the apparent gain on this deal is yet to realized by Telus, we believe that given Wolf Medical system’s 13 years of experience in cloud-based EMR solutions in an industry dominated by big players like Allscripts ( (MDRX - Free Report) and Quality Systems ( (QSII - Free Report) , Telus has a fair chance of seeing success in this technological front and gain advantage over its peers like Rogers Communication ( (RCI - Free Report) and BCE Inc. ( (BCE - Free Report) , which have yet to venture into this business.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: https://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: https://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at https://at.zacks.com/?id=5518.
Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks Investment Research
800-767-3771 ext. 9339